Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Upper gastrointestinal bleeding in patients with CKDChih-Chia Liang, Su-Ming Wang, Huey-Liang Kuo, et al.
Nephrology (Carlton, Vic.)|May 6, 2016
Prolonged QT interval is linked to all-cause and cardiac mortality in chronic peritoneal dialysis patientsHuey-Liang Kuo, Yao-Lung Liu, Chih-Chia Liang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 17, 2014
Association of walking with survival and RRT among patients with CKD stages 3-5I-Ru Chen, Su-Ming Wang, Chih-Chia Liang, et al.
Journal of Cancer|January 3, 2022
Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapiesYu-Chuan Yan, Guang-Xiao Meng, Zi-Niu Ding, et al.
Hepatology (Baltimore, Md.)|December 24, 2019
TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB-EGF Expression and Proteolytic CleavageZhao-Ru Dong, Dong Sun, Ya-Fei Yang, et al.
Frontiers in Oncology|March 8, 2021
Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-AnalysisKai-Xuan Liu, Jian-Guo Hong, Rui Wu, et al.
Expert Review of Gastroenterology & Hepatology|January 10, 2023
The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysisCheng-Long Han, Bao-Wen Tian, Chun-Cheng Yang, et al.
Journal of Cancer|June 7, 2021
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survivalZhao-Ru Dong, Zhi-Qiang Chen, Xiao-Yun Yang, et al.
Immunotherapy|December 20, 2022
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysisBao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, et al.
Expert Review of Gastroenterology & Hepatology|May 6, 2023
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysisHui Liu, Cheng-Long Han, Bao-Wen Tian, et al.
Pageof 6